|
GlaxoSmithKline Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
32881.71 Cr.
|
P/BV
|
18.87
|
Book Value (Rs.)
|
102.89
|
|
52 Week High/Low (Rs.)
|
2524/1227
|
FV/ML
|
10/1
|
P/E(X)
|
53.32
|
|
Bookclosure
|
30/06/2023
|
EPS (Rs.)
|
36.41
|
Div Yield (%)
|
1.65
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 36.08 | 99.29 | 31.35 | 5.50 | 26.29 |
| Diluted EPS (Rs.) | 36.05 | 100.04 | 21.14 | 5.50 | 26.29 |
| Cash EPS (Rs.) | 39.93 | 104.06 | 25.78 | 10.38 | 29.16 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 102.79 | 157.19 | 87.26 | 107.47 | 126.31 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 102.79 | 157.19 | 87.26 | 107.47 | 126.31 |
| Revenue From Operations / Share (Rs.) | 191.95 | 193.50 | 172.70 | 190.33 | 184.65 |
| PBDIT / Share (Rs.) | 53.42 | 49.45 | 41.84 | 43.46 | 41.50 |
| PBIT / Share (Rs.) | 49.54 | 45.42 | 37.20 | 38.58 | 38.64 |
| PBT / Share (Rs.) | 49.37 | 45.99 | 26.80 | 18.05 | 40.30 |
| Net Profit / Share (Rs.) | 36.05 | 100.04 | 21.14 | 5.50 | 26.29 |
| NP After MI And SOA / Share (Rs.) | 36.41 | 100.04 | 21.14 | 5.50 | 26.29 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 27.82 | 25.55 | 24.22 | 22.83 | 22.47 |
| PBIT Margin (%) | 25.80 | 23.47 | 21.53 | 20.26 | 20.92 |
| PBT Margin (%) | 25.72 | 23.76 | 15.51 | 9.48 | 21.82 |
| Net Profit Margin (%) | 18.78 | 51.69 | 12.24 | 2.89 | 14.23 |
| NP After MI And SOA Margin (%) | 18.96 | 51.69 | 12.24 | 2.89 | 14.23 |
| Return on Networth / Equity (%) | 35.41 | 63.64 | 24.22 | 5.11 | 20.81 |
| Return on Capital Employeed (%) | 41.95 | 26.21 | 35.80 | 30.95 | 26.63 |
| Return On Assets (%) | 18.53 | 36.57 | 11.49 | 2.97 | 11.38 |
| Asset Turnover Ratio (%) | 0.80 | 0.83 | 0.93 | 0.91 | 0.79 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.88 | 2.18 | 1.63 | 1.74 | 1.38 |
| Quick Ratio (X) | 1.53 | 1.87 | 1.22 | 1.26 | 1.05 |
| Inventory Turnover Ratio (X) | 0.81 | 1.04 | 0.89 | 0.97 | 1.38 |
| Dividend Payout Ratio (NP) (%) | 247.21 | 29.98 | 189.20 | 363.51 | 66.56 |
| Dividend Payout Ratio (CP) (%) | 223.39 | 28.82 | 155.15 | 192.63 | 60.01 |
| Earning Retention Ratio (%) | -147.21 | 70.02 | -89.20 | -263.51 | 33.44 |
| Cash Earning Retention Ratio (%) | -123.39 | 71.18 | -55.15 | -92.63 | 39.99 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 499.36 | 419.65 | 200.69 | 116.21 | 1268.47 |
| Interest Coverage Ratio (Post Tax) (%) | 336.84 | 185.96 | 131.22 | 69.61 | 752.75 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 21275.97 | 25686.86 | 23243.30 | 20012.10 | 20849.07 |
| EV / Net Operating Revenue (X) | 6.54 | 7.84 | 7.94 | 6.21 | 6.67 |
| EV / EBITDA (X) | 23.51 | 30.67 | 32.80 | 27.18 | 29.65 |
| MarketCap / Net Operating Revenue (X) | 6.90 | 8.59 | 8.34 | 6.54 | 7.04 |
| Retention Ratios (%) | -147.21 | 70.01 | -89.20 | -263.51 | 33.43 |
| Price / BV (X) | 12.88 | 10.58 | 16.51 | 11.59 | 10.29 |
| Price / Net Operating Revenue (X) | 6.90 | 8.59 | 8.34 | 6.54 | 7.04 |
| EarningsYield | 0.02 | 0.06 | 0.01 | 0.00 | 0.02 |